Biogen Provides Free Aduhelm as U.S. Clinics Await Medicare Payment

Published on August 30, 2021

Biogen Inc is providing its controversial and expensive new Alzheimer’s drug free of charge for some patients amid slow claim reviews by Medicare, according to sources familiar with the situation, including a doctor treating patients with the drug. The development…

Read Full Article (External Site)